Table 15.
Drug likeness assessment of the lead compounds based on Ghose, Veber, Egan, Muegge, QED, and Synthetic accessibility scores.
Molecule | Ghose | Veber | Egan | Muegge | QED | SA score |
---|---|---|---|---|---|---|
9 | Yes | No | No | No | 0.62 | 3.148 |
10 | Yes | No | No | No | 0.582 | 3.215 |
11 | Yes | No | No | No | 0.582 | 3.158 |
17 | Yes | No | No | No | 0.549 | 3.25 |
22 | Yes | No | No | No | 0.515 | 3.32 |
31 | Yes | No | No | No | 0.554 | 3.272 |
Oseltamivir | Yes | Yes | Yes | Yes | 0.213 | 4.392 |
Zanamivir | Yes | Yes | Yes | Yes | 0.691 | 3.758 |
Key: Quantitative Estimate of Drug-likeness (QED), Synthetic accessibility (SA) score.